SKVI Stock Overview
Skinvisible, Inc., together with its subsidiaries, focuses on the development, manufacture, and sale of topical, transdermal, and mucosal polymer-based delivery system technologies and formulations for use in pharmaceutical, over the counter, personal skincare, and cosmetic arenas.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Skinvisible, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.061 |
| 52 Week High | US$0.14 |
| 52 Week Low | US$0.055 |
| Beta | -0.39 |
| 1 Month Change | -6.15% |
| 3 Month Change | -12.86% |
| 1 Year Change | -38.38% |
| 3 Year Change | -4.69% |
| 5 Year Change | -76.54% |
| Change since IPO | -99.92% |
Recent News & Updates
Recent updates
Shareholder Returns
| SKVI | US Personal Products | US Market | |
|---|---|---|---|
| 7D | -39.6% | -0.5% | 1.0% |
| 1Y | -38.4% | -28.8% | 21.9% |
Return vs Industry: SKVI underperformed the US Personal Products industry which returned -26% over the past year.
Return vs Market: SKVI underperformed the US Market which returned 24.9% over the past year.
Price Volatility
| SKVI volatility | |
|---|---|
| SKVI Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 8.8% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SKVI's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine SKVI's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 2 | Terry Howlett | www.skinvisible.com |
Skinvisible, Inc., together with its subsidiaries, focuses on the development, manufacture, and sale of topical, transdermal, and mucosal polymer-based delivery system technologies and formulations for use in pharmaceutical, over the counter, personal skincare, and cosmetic arenas. Its non-dermatological formulations offer solutions for women’s health, pain management, and other markets. The company offers sunless tanning and sunscreen products.
Skinvisible, Inc. Fundamentals Summary
| SKVI fundamental statistics | |
|---|---|
| Market cap | US$276.93k |
| Earnings (TTM) | -US$2.38m |
| Revenue (TTM) | US$20.00k |
13.8x
P/S Ratio-0.1x
P/E RatioIs SKVI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SKVI income statement (TTM) | |
|---|---|
| Revenue | US$20.00k |
| Cost of Revenue | US$0 |
| Gross Profit | US$20.00k |
| Other Expenses | US$2.40m |
| Earnings | -US$2.38m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.52 |
| Gross Margin | 100.00% |
| Net Profit Margin | -11,912.20% |
| Debt/Equity Ratio | -68.2% |
How did SKVI perform over the long term?
See historical performance and comparison